Quarterly results for the quarter ended on 31st December 2025 is attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lime Chemicals reported a sharp deterioration in Q3 FY26 (Oct–Dec 2025). Revenue from operations fell to Rs. 153.17 lakhs, down about 41% from Rs. 260.28 lakhs in the same quarter last year. For the nine months ended Dec 2025, revenue dropped nearly 40% to Rs. 483.88 lakhs versus Rs. 802.63 lakhs a year ago. The company swung to a loss before tax of Rs. 7.97 lakhs in Q3 (vs. Rs. 6.35 lakh profit YoY) and a loss of Rs. 20.52 lakhs for 9M FY26 (vs. Rs. 16.26 lakh profit YoY). Loss per share for the quarter stood at Rs. 0.14 versus earnings of Rs. 0.09 earlier. The auditor (R.A. Kuvadia & Co.) issued an unmodified (unqualified) limited review opinion. A note mentions Rs. 36.25 lakhs of MSME interest not provided for, pending a quality dispute with a supplier.
Weakening top line and a return to losses signal pressure on the business — likely negative for the stock in the near term. Existing shareholders should watch for improvement in volumes and cost discipline in coming quarters before taking fresh exposure.